About Interlace Medical
Interlace Medical is a company based in Framingham (United States) founded in 2006 was acquired by Hologic in January 2011. Interlace Medical has raised $32.5 million across 3 funding rounds from investors including Hologic, New Leaf Venture Partners and Tekla Capital Management. Interlace Medical operates in a competitive market with competitors including Gynesonics, Channel Medsystems, Minerva Surgical, nVision Medical and Yingzi Medical, among others.
- Headquarter Framingham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Interlace Medical, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Interlace Medical
Interlace Medical has successfully raised a total of $32.5M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $20.5 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Interlace Medical
Interlace Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, New Leaf Venture Partners and Tekla Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in expansion stage tech and life sciences companies in the US
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life sciences are managed.
|
Locked | Locked | Locked | |
|
Global private equity and venture capital investments in B2B Tech & Services companies.
|
Locked | Locked | Locked |
Investor details for Interlace Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Interlace Medical
Investment portfolio details for Interlace Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Interlace Medical
Detailed financials for Interlace Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Interlace Medical Comparisons
Peer comparison for Interlace Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Interlace Medical
Interlace Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gynesonics, Channel Medsystems, Minerva Surgical, nVision Medical and Yingzi Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A minimally invasive ablation system for uterine fibroids is developed.
|
|
| Locked | Locked | Locked |
Cryothermic technology for endometrial ablation to control heavy bleeding
|
|
| Locked | Locked | Locked |
Minerva Surgical is focused on uterine health solutions.
|
|
| Locked | Locked | Locked |
Medical devices for women's health and infertility treatment are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of minimally invasive gynecological medical devices and systems. The company develops and produces a range of products for hysteroscopic procedures, cervical health management, female rehabilitation, and gynecological diagnostics. These products are designed to improve clinical outcomes and enhance the patient experience. The company also provides medical training programs to support the use of its technologies.
|
Detailed competitors of Interlace Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Interlace Medical
Complete news archive for Interlace Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Interlace Medical
Interlace Medical was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Interlace Medical is headquartered in Framingham, United States. It is registered at Framingham, Massachusetts, United States.
Interlace Medical is a funded company, having raised a total of $32.5M across 3 funding rounds to date.
Interlace Medical was founded in 2006 in Framingham, United States, within the medical devices sector focused on gynecology. Devices are developed for interventional gynecologists to enable office-based treatments for conditions such as submucosal fibroids and polyps, reducing the need for operating room surgeries. Key products include the MyoSure hysteroscopic tissue removal system. The company was acquired by Hologic in January 2011.
Interlace Medical's top competitors include Gynesonics, Channel Medsystems and Minerva Surgical.
Interlace Medical has 7 investors. Key investors include Hologic, New Leaf Venture Partners, Tekla Capital Management, HLM Venture Partners, and Baird Capital.